- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- January 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,513GBP
- Report
- June 2026
- 288 Pages
Global
From €5280EUR$5,850USD£4,577GBP
- Report
- June 2026
- 383 Pages
Global
From €5280EUR$5,850USD£4,577GBP
- Report
- June 2026
- 373 Pages
Global
From €5280EUR$5,850USD£4,577GBP
- Report
- January 2026
- 130 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- January 2026
- 120 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- January 2026
- 317 Pages
Global
From €4287EUR$4,750USD£3,717GBP
- Report
- August 2025
- 170 Pages
Global
From €3248EUR$3,599USD£2,816GBP
- Report
- August 2025
- 150 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- July 2025
- 350 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP

Process Development in biotechnology is the process of designing, optimizing, and validating manufacturing processes for biopharmaceuticals. It involves the development of processes for the production of biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and vaccines. The process development process includes the development of analytical methods, process characterization, process optimization, and process validation. It also involves the development of process control strategies, such as process monitoring and process control systems.
Process development is a critical step in the development of biopharmaceuticals, as it ensures that the product is safe, effective, and of high quality. It is also important for the efficient and cost-effective production of biopharmaceuticals.
Companies in the Process Development market include Merck, Pfizer, Novartis, Amgen, and Genentech. Show Less Read more